Copaxone Subcutaneous Injection Syringe Special Drug Use-Result Investigation (All-Case Investigation) "Prevention of Relapse of Multiple Sclerosis"
Latest Information Update: 18 Jun 2024
At a glance
- Drugs Glatiramer acetate (Primary)
- Indications Multiple sclerosis
- Focus Adverse reactions; Therapeutic Use
- Sponsors Takeda; Teva Pharmaceutical Industries
- 22 Apr 2024 Status changed from active, no longer recruiting to completed.
- 24 Dec 2023 Planned End Date changed from 31 Mar 2025 to 31 Mar 2024.
- 24 Dec 2023 Planned primary completion date changed from 31 Mar 2025 to 31 Mar 2024.